TECX ▲ +6.3% - Tectonic Therapeutic, Inc. $TECX - Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT) 29-SEP-2026 08:03 AM ET